Cargando…

Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of gastrointestinal (GI) tract with dysregulated mucosal immune functions and disturbed commensal ecosystem of the intestinal lumen. IBD is categorized into two major subsets: Crohn's disease (CD) and ulcerative colitis (UC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mishra, Jayshree, Stubbs, Madyson, Kuang, Longxiang, Vara, Nitza, Kumar, Priyam, Kumar, Narendra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786545/ https://www.ncbi.nlm.nih.gov/pubmed/35082553 http://dx.doi.org/10.1155/2022/9621668

Ejemplares similares

Mucosal Epithelial Jak Kinases in Health and Diseases
por: Kumar, Narendra, et al.
Publicado: (2021)

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
por: Owaga, Eddy, et al.
Publicado: (2015)

Role of commensal and probiotic bacteria in human health: a focus on inflammatory bowel disease
por: Martín, Rebeca, et al.
Publicado: (2013)

The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review
por: Zhang, Tao, et al.
Publicado: (2023)

Mechanistic Role of Jak3 in Obesity-Associated Cognitive Impairments
por: Kumar, Premranjan, et al.
Publicado: (2022)

Probiotics in Inflammatory Bowel Diseases and Associated Conditions
por: Mack, David R.
Publicado: (2011)

Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
por: Akutko, Katarzyna, et al.
Publicado: (2021)

Next-Generation Probiotics for Inflammatory Bowel Disease
por: Pesce, Marcella, et al.
Publicado: (2022)

Probiotics in Irritable Bowel Syndrome: A Review of Their Therapeutic Role
por: Satish Kumar, Lakshmi, et al.
Publicado: (2022)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin
por: Mishra, Jayshree, et al.
Publicado: (2017)

Factors associated with the use of probiotics in patients with inflammatory bowel disease
por: Agathou, Claire Louise, et al.
Publicado: (2013)

Probiotics in Inflammatory Bowel Disease: Are We Back to Square One?
por: Puvvada, Suvarna Rekha, et al.
Publicado: (2020)

Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases
por: Mazur, Marzena, et al.
Publicado: (2021)

Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases
por: Barra, Maria, et al.
Publicado: (2020)

Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function
por: Schoultz, Ida, et al.
Publicado: (2019)

Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease
por: Bernardazzi, Claudio, et al.
Publicado: (2016)

Probiotics and Vitamin D/Vitamin D Receptor Pathway Interaction: Potential Therapeutic Implications in Inflammatory Bowel Disease
por: Pagnini, Cristiano, et al.
Publicado: (2021)

The clinical effects of probiotics for inflammatory bowel disease: A meta-analysis
por: Jia, Kai, et al.
Publicado: (2018)

Probiotic yogurt Affects Pro- and Anti-inflammatory Factors in Patients with Inflammatory Bowel Disease
por: Shadnoush, Mahdi, et al.
Publicado: (2013)

An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models
por: Chua, Koon Jiew, et al.
Publicado: (2022)

Inflammatory Bowel Disease Drugs: A Focus on Autophagy
por: Hooper, Kirsty M., et al.
Publicado: (2017)

Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases
por: Aggarwal, Surbhi, et al.
Publicado: (2021)

Inflammatory Bowel Disease: Focus on Enteropathic Arthritis and Therapy
por: Barkhodari, Amir, et al.
Publicado: (2022)

Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease
por: Lee, Hoyul, et al.
Publicado: (2023)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy
por: Mishra, Rangnath, et al.
Publicado: (2020)

Phages and Their Role in Gastrointestinal Disease: Focus on Inflammatory Bowel Disease
por: Maronek, Martin, et al.
Publicado: (2020)

The clinical effects of probiotics for inflammatory bowel disease: A meta-analysis: Erratum
Publicado: (2019)

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
por: Jakubczyk, Dominika, et al.
Publicado: (2020)

The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease
por: Stojanov, Spase, et al.
Publicado: (2020)

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease
por: Li, Lingfeng, et al.
Publicado: (2022)

Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
por: Liu, Jun, et al.
Publicado: (2022)

Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
por: Roy, Supriya, et al.
Publicado: (2023)

Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
por: Park, Sung Chul, et al.
Publicado: (2019)

Growth Hormone Resistance—Special Focus on Inflammatory Bowel Disease
por: Soendergaard, Christoffer, et al.
Publicado: (2017)

Prophylactic vs. Therapeutic Effect of Probiotics on the Inflammation Mediated by the NF-κB Pathway in Inflammatory Bowel Conditions
por: Najafi, Saeideh, et al.
Publicado: (2023)

Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
por: Ghouri, Yezaz A, et al.
Publicado: (2014)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jn2gc1mpadhpvijepe2vrpci6u